Zhejiang Hospital, Hangzhou, 310030, China.
The Third People's Hospital of Chengdu, Chengdu, 610014, China.
BMC Geriatr. 2024 Jun 7;24(1):506. doi: 10.1186/s12877-024-05038-6.
This study was conducted in Urumqi, Xinjiang, to assess the prevalence of sarcopenia and to determine the relationship between physical activity, nutritional status, and sarcopenia among community-dwelling patients with type 2 diabetes mellitus.
Four hundred eight cases of older people patients with type 2 diabetes mellitus in the community in Urumqi, Xinjiang, from May to August 2022 were selected for a cross-sectional on-site survey, and general information questionnaires, clinical information surveys, physical function measurements, and criteria developed by the Asian sarcopenia working group in 2019 were selected for diagnosis of sarcopenia, and unifactorial and multifactorial binary Logistic regression were applied to analyze the influencing factors of T2DM combined with sarcopenia in patients with sarcopenia.
Among the 408 patients, 84 (20.6%) had sarcopenia, with a prevalence of 12.6%, 32.1%, and 51.9% in those aged 60-70, 71- 80, and 81 or older respectively. The prevalence increased significantly with age. Adjusting for variables, the study found that FFM of the Left Leg (OR: 0.710, 95% CI: 0.612-0.804, P = 0.024), FFM of the Right Arm (OR: 0.710, 95% CI: 0.612-0.804, P < 0.001), Age (OR: 1.246, 95% CI: 1.031-1.505, P = 0.023), Fasting Blood Glucose (OR: 1.649, 95% CI: 1.066-2.550, P = 0.025), and Post-Prandial Blood Glucose (OR: 1.455, 95% CI: 0.999-2.118, P = 0.025) were independent associated factors. An increase in MNA score (OR: 0.398, 95% CI: 0.244-0.6500, P < 0.001), ASMI (OR: 0.000, 95% CI: 0.00-0.01, P < 0.001) walking energy expenditure (MET-min) (OR: 0.998, 95% CI: 0.996-0.999, P = 0.001) reduced the prevalence of sarcopenia.
This study shows that increased age, increased skeletal muscle mass index, decreased right arm FFM, increased postprandial glucose, increased MNA scores, and increased walking energy expenditure (MET-min) were associated with type 2 diabetes with sarcopenia.
本研究在新疆乌鲁木齐进行,旨在评估社区 2 型糖尿病患者中肌少症的患病率,并确定身体活动、营养状况与肌少症之间的关系。
2022 年 5 月至 8 月,采用横断面现场调查的方法,选择乌鲁木齐市社区 408 例老年 2 型糖尿病患者,采用一般情况问卷、临床资料调查、身体功能测量和 2019 年亚洲肌少症工作组制定的标准进行肌少症诊断,采用单因素和多因素二项 Logistic 回归分析肌少症患者 T2DM 合并肌少症的影响因素。
408 例患者中,84 例(20.6%)患有肌少症,60-70 岁、71-80 岁和 81 岁及以上患者的患病率分别为 12.6%、32.1%和 51.9%。患病率随年龄增长而显著增加。调整变量后,研究发现左侧腿部 FFM(OR:0.710,95%CI:0.612-0.804,P=0.024)、右侧手臂 FFM(OR:0.710,95%CI:0.612-0.804,P<0.001)、年龄(OR:1.246,95%CI:1.031-1.505,P=0.023)、空腹血糖(OR:1.649,95%CI:1.066-2.550,P=0.025)和餐后血糖(OR:1.455,95%CI:0.999-2.118,P=0.025)是独立的相关因素。MNA 评分升高(OR:0.398,95%CI:0.244-0.6500,P<0.001)、ASMI(OR:0.000,95%CI:0.00-0.01,P<0.001)、步行能量消耗(MET-min)(OR:0.998,95%CI:0.996-0.999,P=0.001)降低与肌少症患病率降低相关。
本研究表明,年龄增长、骨骼肌质量指数增加、右侧手臂 FFM 减少、餐后血糖升高、MNA 评分升高和步行能量消耗(MET-min)增加与 2 型糖尿病合并肌少症有关。